DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Alferon N Injection (Interferon Alfa-N3) - Current Clinical Trials

 
 



Clinical Trials Related to Alferon N Injection (Interferon Alfa-N3)

Zidovudine, Interferon Alfa-2b, and PEG-Interferon Alfa-2b in Treating Patients With Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia/Lymphoma [Terminated]

Recombinant Interferon Alfa-2b in Treating Patients With Melanoma [Active, not recruiting]

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery [Completed]

Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer [Completed]

Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis [Terminated]

Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Terminated]

Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer [Terminated]

Study of Alferon� LDO (Low Dose Oral) in Normal Volunteers [Completed]

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma [Completed]

Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer [Terminated]

Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma [Completed]

Interferon Alpha Lozenges in the Prevention of Winter Colds and Flu [Completed]

Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study [Recruiting]

Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia [Active, not recruiting]

Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors [Completed]

Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C [Completed]

Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma [Terminated]

Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA) [Completed]

A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects [Terminated]

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma [Completed]

The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma [Withdrawn]

Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma [Completed]

The Effect of Postoperative Interferon- Alpha Treatment in Low miR-26 Expression Patients With HCC [Recruiting]

Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a [Completed]

Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer [Completed]

Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) [Recruiting]

Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies [Completed]

Phase II Study of KW2871 Combined With High Dose Interferon-alpha2b in Patients With Metastatic Melanoma [Active, not recruiting]

Pegylated Interferon Alpha-2b and Capecitabine in Unresectable/Metastatic Cutaneous Squamous Cell [Recruiting]

Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4 [Active, not recruiting]

Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C [Completed]

Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment [Completed]

High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery [Not yet recruiting]

Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients [Recruiting]

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa [Completed]

Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery [Completed]

Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta [Recruiting]

Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients [Active, not recruiting]

Study to Evaluate Sodium Stibogluconate With Interferon Alpha-2b [Withdrawn]

Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors [Terminated]

A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols [Completed]

Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas [Completed]

Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C [Completed]

Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin [Completed]

Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection [Completed]

Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium [Completed]

Pegasys in Patients With Myeloproliferative Diseases [Active, not recruiting]

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis [Completed]

Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas [Recruiting]

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer [Terminated]

Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer [Completed]

PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [Terminated]

Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma [Recruiting]

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3 [Completed]

Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) [Recruiting]

Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase I Study in Chinese Healthy Volunteers [Completed]

Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma [Completed]

Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma [Recruiting]

Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB) [Recruiting]

Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC) [Not yet recruiting]

Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma [Active, not recruiting]

Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm [Completed]

A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma [Completed]

A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma [Completed]

Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines [Terminated]

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1) [Completed]

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies [Terminated]

Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders [Completed]

Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) [Completed]

Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer [Completed]

Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia [Completed]

Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis [Completed]

Interferon Alfa in Treating Children With HIV-Related Cancer [Completed]

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma [Active, not recruiting]

Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects [Completed]

A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma [Completed]

Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis [Completed]

An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection [Completed]

Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed [Completed]

A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus [Completed]

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer [Completed]

Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin [Terminated]

Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC [Terminated]

Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression [Terminated]

Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCV [Completed]

Combined Use of BCG and Interferon Alpha in Bladder Cancer [Completed]

A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection [Completed]

Pharmacokinetics and Pharmacodynamics of Interferon Alpha 2A [Completed]

An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation [Completed]

Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders [Completed]

P1101 in Treating Patients With Early Myelofibrosis [Not yet recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015